Cyclo-oxygenase-2 inhibitors ad COPD: a bright spot?

Effros, R. M.; Casaburi, R.
October 2005
Thorax;Oct2005, Vol. 60 Issue 10, p796
Academic Journal
Cites a study which discusses the usefulness of exhaled breath condensate for various inflammatory events in the lungs. Role of cyclo-oxygenase inhibitors activity in protecting the airways; Usefulness of exhaled breath condensate (EBC) as a simple non-invasive method for inflammatory events in the lungs; Statement that EBC samples are collected by cooling expired air and collecting the water which condenses on the surfaces of the collecting device.


Related Articles

  • The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Müller, N.; Schwarz, M. J.; Dehning, S.; Douhe, A.; Cerovecki, A.; Goldstein-Müller, B.; Spellmann, I.; Hetzel, G.; Maino, K.; Kleindienst, N.; Möller, H.-J.; Arolt, V.; Riedel, M. // Molecular Psychiatry;Jul2006, Vol. 11 Issue 7, p680 

    Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E2 (PGE2), have repeatedly been described in major depression (MD). As cyclooxygenase-2 (COX-2) inhibitors inhibit the PGE2 production and the production of...

  • Interaction of rofecoxib and celecoxib with warfarin. Schaefer, Monica G.; Plowman, Brian K.; Morreale, Anthony P.; Egan, Melissa // American Journal of Health-System Pharmacy;7/1/2003, Vol. 60 Issue 13, p1319 

    The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200...

  • Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. Junya Ozawa; Akinori Kaneguchi; Ryo Tanaka; Nobuhiro Kito; Hideki Moriyama // BMC Musculoskeletal Disorders;10/24/2016, Vol. 17, p1 

    Background: The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2 mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the effectiveness of oral administration of non-steroidal anti-inflammatory drug...

  • Effect of cyclooxygenase-2 inhibitor pretreatment on gas exchange after hydrochloric acid aspiration in rats. Terao, Yoshiaki; Nakamura, Toshiaki; Morooka, Hiroaki; Sumikawa, Koji // Journal of Anesthesia;2005, Vol. 19 Issue 3, p257 

    The present study was carried out to determine the effect of cyclooxygenase-2 (COX-2) inhibitor on acid aspiration-induced lung injury in rats. Rats were allocated into one of four groups. Group H received intratracheal instillation of HCl. Group S received saline intratracheally. Group HC...

  • Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors. Cheng, H. F.; Harris, R. C. // Current Pharmaceutical Design;May2005, Vol. 11 Issue 14, p1795 

    Nonsteroidal antiinflammatory drugs (NSAID) are one of the most commonly used medications worldwide to inhibiting COX activity for the treatment of pain and inflammation. Their nephrotoxicity has been well documented. With the development and clinical implementation of new COX-2 inhibitors, the...

  • Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial. Zhang, R. X.; Wu, X. J.; Wan, D. S.; Lu, Z. H.; Kong, L. H.; Pan, Z. Z.; Chen, G. // Annals of Oncology;May2012, Vol. 23 Issue 5, p1348 

    Background: Hand-foot syndrome (HFS) is the most common adverse event induced by capecitabine. Some clinicians think that HFS is a type of inflammation limited to the hands and feet and can be prevented with a COX-2 inhibitor (celecoxib). Methods: We designed a single-center, prospective...

  • A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation. Di Penta, Alessandra; Chiba, Asako; Alloza, Iraide; Wyssenbach, Ane; Yamamura, Takashi; Villoslada, Pablo; Miyake, Sachiko; Vandenbroeck, Koen // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor. We have previously shown that celecoxib inhibits experimental autoimmune encephalomyelitis (EAE) in COX-2-deficient mice, suggestive for a mode of action involving COX2-independent pathways. In the present study, we tested the effect of...

  • The murky waters of the coxibs: a review of the current state of play. Ostor, Andrew J. K.; Hazleman, Brian L. // Inflammopharmacology;2005, Vol. 13 Issue 4, p371 

    Since their development and licencing no class of drug has received as much attention both in the scientific and lay press as the cyclo-oxygenase 2 (COX-2) inhibitors. These compounds, also known as coxibs, were developed as a safer alternative to traditional non-steroidal anti-inflammatory...

  • PROTECTIVE EFFECT OF CELECOXIB ON NICOTINE TOXICITY AND ALTERATIONS IN TRACE ELEMENT LEVELS. Ünüvar, Songül; Aktay, Göknur // Turkish Journal of Pharmaceutical Sciences;2011, Vol. 8 Issue 3, p189 

    The aim of this study was to investigate alterations in trace elements such as Copper (Cu) and Zinc (Zn) levels in rat tissues, body weights and liver weights dependent on nicotine exposure, and discuss the protective effect of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor. We...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics